This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francois, G.
Right arrow Articles by Bringmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francois, G.
Right arrow Articles by Bringmann, G.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., 11 1997, 2533-2539, Vol 41, No. 11
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Naphthylisoquinoline alkaloids against malaria: evaluation of the curative potentials of dioncophylline C and dioncopeltine A against Plasmodium berghei in vivo

G Francois, G Timperman, W Eling, LA Assi, J Holenz and G Bringmann
Prins Leopold Instituut voor Tropische Geneeskunde, Antwerp, Belgium.

Naphthylisoquinoline alkaloid-containing extracts from species of the families Dioncophyllaceae and Ancistrocladaceae and purified alkaloids derived therefrom were shown to exhibit antiparasitic activity in Plasmodium berghei-infected mice. Several extracts and alkaloids, especially dioncophylline C and dioncopeltine A, isolated from Triphyophyllum peltatum (Dioncophyllaceae), displayed high levels of activity. Dioncopeltine A was able to suppress parasitemia almost totally, while dioncophylline C cured infected mice completely after oral treatment with 50 mg kg of body weight(-1) day(-1) for 4 days without noticeable toxic effects. Analysis of the dose-response relationship of dioncophylline C revealed a 50% effective dosage (ED50) of 10.71 mg kg(-1) day(-1) under these conditions. Although four daily treatments with 50 mg kg(-1) day(-1) are needed to achieve radical cure, one oral dose is sufficient to kill 99.6% of the parasites. Intravenous application of dioncophylline C is even more effective, with an ED50 of 1.90 mg kg(-1) day(-1) and no noticeable toxic effects. The compound also suppressed more established P. berghei infections when orally applied at day 3 after infection. Both dioncopeltine A and dioncophylline C are active against the chloroquine-resistant P. berghei Anka CRS parasites. Sustained release of these compounds at 20 mg kg(-1) day(-1) by implanted miniosmotic pumps exhibited curative effects. The naphthylisoquinoline alkaloids are therefore promising new antimalarial agents.


This article has been cited by other articles:

  • Ponte-Sucre, A., Faber, J. H., Gulder, T., Kajahn, I., Pedersen, S. E. H., Schultheis, M., Bringmann, G., Moll, H. (2007). Activities of Naphthylisoquinoline Alkaloids and Synthetic Analogs against Leishmania major. Antimicrob. Agents Chemother. 51: 188-194 [Abstract] [Full Text]  
  • Bringmann, G., Feineis, D. (2001). Stress-related polyketide metabolism of Dioncophyllaceae and Ancistrocladaceae. J Exp Bot 52: 2015-2022 [Abstract] [Full Text]